Companies Law, 1999 (Israel)

Companies Law, 1999 (Israel)
Name	Companies Law, 1999 (Israel)
Enacted	1999
Jurisdiction	State of Israel
Long title	An Act consolidating and modernizing corporate regulation in Israel
Status	in force

Companies Law, 1999 (Israel) is the principal statutory framework regulating the formation, governance, capital structure and dissolution of corporations in the State of Israel. The law replaced the Companies Ordinance 1929 and sought to harmonize Israeli corporate practice with international standards exemplified by statutes such as the United Kingdom Companies Act 1985, the Delaware General Corporation Law, and directives emerging from the Organisation for Economic Co-operation and Development. It has been central to disputes involving prominent entities like Teva Pharmaceutical Industries, Bank Hapoalim, and Bank Leumi, and has influenced litigation before the Supreme Court of Israel and adjudication in the Tel Aviv District Court.

Background and enactment

The enactment process involved legislative bodies such as the Knesset and committees like the Constitution, Law and Justice Committee, with contributions from legal scholars affiliated with institutions including the Hebrew University of Jerusalem, Tel Aviv University, and Bar-Ilan University. Drafting drew comparative models from the Companies Act 2006 of the United Kingdom, the corporate codes of the United States, and academic commentary by figures connected to the Israel Bar Association. Political events affecting the law’s passage included debates involving ministers from cabinets chaired by leaders such as Benjamin Netanyahu and Ehud Barak. After promulgation, regulatory oversight was vested partly in the Registrar of Companies and enforcement involved the State Attorney (Israel) and administrative bodies like the Israel Securities Authority.

Scope and key definitions

The statute defines corporate forms similar to those in other jurisdictions, including limited liability companies and public companies, drawing terminology comparable to definitions in the European Union corporate acquis and cases from the International Court of Justice where corporate personality issues arise. Key defined actors include directors akin to fiduciaries analyzed in precedents like Re Smith & Fawcett (UK) and officer roles discussed in writings by scholars from Columbia Law School and Harvard Law School. The law distinguishes between entities subject to disclosure regimes enforced by the Israel Securities Authority and firms covered by the Companies (Auditors) Law and intersections with the Banking (Licensing) Law, 1981 when banking groups such as Hapoalim are implicated.

Corporate formation and registration

Registration procedures require submission to the Registrar of Companies and compliance with documentation traditions comparable to filings before the Companies House in the United Kingdom or the Delaware Division of Corporations. Founders and incorporators include individuals and entities with capacities judged against standards developed by jurists at the Supreme Court of Israel and commentators from the Israeli Corporate Counsel Association. Statutory instruments echo international templates used by multinationals like Intel and IBM when forming Israeli subsidiaries, and registration outcomes affect relationships with institutions such as the Israel Tax Authority and regulators like the Ministry of Justice (Israel).

Governance and management provisions

The law codifies director duties and board structures, reflecting debates prominent in cases involving corporations like Bezeq and Elbit Systems. Provisions on board committees, executive powers, and appointment procedures engage doctrines seen in decisions from the Supreme Court of the United States and scholarly texts from Yale Law School and New York University School of Law. Corporate governance reforms following high-profile scandals involving entities such as Bank Leumi prompted alignments with standards promoted by organizations like the OECD and the World Bank.

Share capital, shareholders' rights and meetings

Regulation of share issuance, pre-emptive rights, and capital alterations parallels mechanisms in the Companies Act 2006 and practice in jurisdictions like Delaware. Shareholder meeting rules and remedies reflect precedents from disputes involving conglomerates like IDB Group and listed firms on the Tel Aviv Stock Exchange, with interactions among shareholder rights discussed in journals affiliated with Hebrew University of Jerusalem Faculty of Law and law firms advising companies including Noble Energy.

Duties, liabilities and enforcement

The statute prescribes fiduciary duties, standards of care, and civil and criminal liabilities, enforced through actions by minority shareholders, derivative suits, and regulatory prosecutions before bodies such as the District Courts of Israel. Enforcement patterns mirror themes from cases involving Shari Arison and corporations like Frutarom, and are informed by comparative rulings from tribunals such as the European Court of Justice and the United States Court of Appeals for the Second Circuit. Auditors regulated under the law coordinate with professional bodies like the Institute of Certified Public Accountants in Israel.

Amendments, judicial interpretation and impact

Subsequent amendments have addressed disclosure, director conflicts, and corporate groups, influenced by rulings of the Supreme Court of Israel and statutory reforms reflecting international pressures from entities like the International Monetary Fund and the World Bank. Judicial interpretation in cases involving major players such as Teva Pharmaceutical Industries and banks have shaped doctrines on piercing the corporate veil, minority protection, and directors’ duties, informing academic debate at centers like the Israel Democracy Institute and policy at the Ministry of Finance (Israel). The law’s evolution continues to affect corporate practice for firms engaged with markets including the Nasdaq and the Tel Aviv Stock Exchange.

Category:Law of Israel